NRx Pharmaceuticals
-
NRx in Radnor Pens $345M+ Deal to Market Bipolar Drug
NRx Pharmaceuticals in Radnor has signed a licensing deal for its new drug candidate targeting bipolar depression, writes John George for Philadelphia Business Journal. The…
-
NRx in Radnor Asks Again for Approval to Use Its COVID-19 Drug, Zyesami
NRx Pharmaceuticals out of Radnor has once again filed an application with the Food and Drug Administration for emergency use of its experimental COVID-19 drug…
-
Promising Results From COVID Drug Pushes Up Radnor Pharm’s Stock
Patients treated with an NRx Pharmaceuitcals drug candidate targeting COVID-19 showed “substantial improvement,” an analysis shows. The news caused the Radnor company’s stock to…
-
NRx in Radnor Has Stock Sale to Raise Funds for COVID Drug, Vaccine Research
A Radnor pharmaceutical company , NRx, active in COVID-19 research is entering into a multi-million dollar private stock sale, writes John George for Philadelphia Business…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
